Developing analgesics from Brazilian biodiversity to treat neuropathic pain

The project, entitled “Aliança Dor” [Pain Alliance], is co-funded by EMBRAPII within the Basic Bioeconomy Funding Alliance modality and also involves the Cristália and Phytobios companies, along with the startup Nintx and the FMRP/USP EMBRAPII unit. The objective of the project, which started in 2023, is to develop standardized molecules or extracts from Brazilian biodiversity to treat neuropathic pain, considering modulation of the microbiota. The project involves creating a high value added prototype to drive sustainable chains and pharmaceutical innovation, adding value to Brazil’s biomes and science.